Specifically, silencing of ZNF217 results in reduced proliferation in several breast cancer cell lines (including MCF-7), and overexpression of ZNF217 increases proliferation in the same cell lines as well as in xenograft tumors (Thollet et al. 2010). This evidence concerns the gene ZNF217 and breast cancer.